Amphastar’s generic drug gets FDA nod to treat severe hypoglycemia
The generic glucagon is a synthetic version of human glucagon, a hormone that causes the liver to increase…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
29 Dec 20
The generic glucagon is a synthetic version of human glucagon, a hormone that causes the liver to increase…
06 Oct 20
Aermony RespiClick is packaged in an advanced device to simplify the administration of inhaled therapy and reduce miscalculations…
03 Apr 20
The companies will combine expertise to discover and develop fully human neutralising antibodies targeting SARS-CoV-2
19 Mar 20
The data shared by Lundbeck is essential to CPAD’s work in creating a disease progression model across the…
Moderna has already given a dose of its potential Covid-19 vaccine to a patient
08 Jan 20
Cerebral Therapeutics develops drug-device combination therapies for patients suffering from severe refractory epilepsy and other neurological diseases
22 Nov 19
IN.PACT AV DCB enables the drug to penetrate deep into the vessel wall to prevent the restenosis and…
04 Oct 19
The MedicaSafe SmartKey records details of each dispensation and transfers data to a cloud portal for prescriber review
14 May 19
SHL Group is exhibiting at the 2019 BIO International Convention in Philadelphia, Pennsylvania, USA from 3-6 June
03 May 19
After announcing a partnership with the Research Center for Respiratory Diseases (CEPR) of Inserm/University of Tours in April…